According to Fortune Business Insights, the global Transcatheter Embolization and Occlusion Devices Market was valued at USD 6.01 billion in 2025 and is projected to grow from USD 6.48 billion in 2026 to USD 11.84 billion by 2034, registering a CAGR of 7.82% during 2026–2034. Increasing adoption of minimally invasive procedures, rising prevalence of cardiovascular and neurovascular disorders, and growing demand for advanced interventional radiology treatments are supporting market expansion.
Transcatheter embolization and occlusion devices are increasingly used for vascular embolization, aneurysm treatment, tumor management, gastrointestinal bleeding control, and other complex interventions. Their ability to support targeted treatment while reducing surgical trauma and hospitalization time is contributing to wider adoption across healthcare facilities.
The growing preference for minimally invasive cardiovascular, neurovascular, and oncology procedures is a major factor driving market growth. Catheter-based interventions can reduce surgical trauma, recovery periods, and hospital stays compared with certain conventional procedures. Healthcare systems are also investing in catheterization laboratories, interventional radiology infrastructure, advanced imaging systems, and precision-guided technologies to meet rising procedural demand.
The increasing burden of aneurysms, vascular malformations, gastrointestinal bleeding, and other vascular conditions is creating demand for embolization and occlusion technologies. Advancements in microcatheters, embolic materials, and image-guided procedures are further supporting adoption by enabling physicians to target specific blood vessels with greater procedural control.
Manufacturers are developing next-generation detachable coils, bioactive embolization materials, precision-controlled occlusion devices, and advanced liquid embolic systems. AI-integrated imaging, 3D vascular mapping, and robotic-assisted catheter navigation are also emerging as important technological developments because they can improve treatment planning and embolization accuracy. Growing adoption of outpatient procedures is additionally encouraging demand for compact and flexible catheter-based devices.
For detailed market insights, visit: https://www.fortunebusinessinsights.com/transcatheter-embolization-and-occlusion-devices-market-117410
The expansion of interventional oncology and neurovascular treatments is creating new opportunities for device manufacturers. Embolization technologies are increasingly utilized in targeted tumor management, aneurysm treatment, arteriovenous malformation procedures, and other vascular interventions. Emerging healthcare markets are also investing in interventional radiology infrastructure, creating opportunities for companies offering advanced coils, liquid embolics, vascular plugs, and robotic-assisted systems.
Based on product, the market is segmented into coil and non-coil devices. The coil segment accounted for approximately 61% of the market, making it the leading product category. Coil embolization devices are widely used in neurovascular interventions, aneurysm treatment, and peripheral vascular procedures because they provide controlled vascular occlusion. Manufacturers are developing detachable, bioactive, and hydrogel-coated coils to improve procedural effectiveness.
The non-coil segment accounted for approximately 39% of the market and includes liquid embolics, vascular plugs, microspheres, and polymer-based occlusion systems. Increasing adoption in oncology, trauma management, and peripheral vascular procedures is supporting segment development.